TAMs can be further classified into subsets based on surface markers such as M1-TAMs (CD86+CD206−), which may mediate proinflammatory and anti-tumor responses, and M2-TAMs (CD206+), which are thought to be immunosuppressive and promote tumor growth [26, 28]. The gene discussed is CD86; the disease is neoplasm.